☆ 4.8 Article

Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix

ONCOGENE (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication Stress

Xiangyan Jiang et al.

Summary: Gemcitabine remains the first-line drug for pancreatic cancer (PC) treatment, but gemcitabine resistance is common and limits long-term survival. This study identified ubiquitin-conjugating enzyme E2T (UBE2T) as a potential therapeutic target to combat gemcitabine resistance in PC. UBE2T promotes gemcitabine resistance in PC by degrading p53 and promoting pyrimidine biosynthesis. Additionally, a UBE2T inhibitor and gemcitabine sensitizer, pentagalloylglucose, was found to effectively inhibit tumor growth and prolong survival in PC mouse models.

GASTROENTEROLOGY (2023)

Add to Collection

Article Oncology

MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells

Emeric Limagne et al.

Summary: Chemotherapy combined with MEK inhibitor enhances the sensitivity of lung cancer cells to immune checkpoint inhibitors by inducing CXCL10 expression and CD8(+) T cell recruitment. The study also highlights the role of TLR9- and OPTN-dependent mitophagy in enhancing the efficacy of chemoimmunotherapy.

CANCER CELL (2022)

Add to Collection

Article Cell Biology

TRIB3 reduces CD8+ T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer

Shuang Shang et al.

Summary: TRIB3 inhibits CD8(+) T cell infiltration in colorectal cancer by inhibiting STAT1 activation and reducing tumor-infiltrating T cells. Acetyltransferase P300 acetylates TRIB3 and prevents its ubiquitination and degradation. Genetic ablation of TRIB3 or pharmacological acceleration of TRIB3 degradation with a P300 inhibitor increases T cell recruitment and sensitizes colorectal cancers to immune checkpoint blockade therapy.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Add to Collection

Review Oncology

Hallmarks of Cancer: New Dimensions

Douglas Hanahan

Summary: The concept of the hallmarks of cancer is a tool for simplifying the complexity of cancer phenotypes and genotypes into basic principles. This article proposes phenotypic plasticity and disrupted differentiation as distinct hallmark capabilities, and discusses nonmutational epigenetic reprogramming and polymorphic microbiomes as enabling characteristics. Additionally, the importance of senescent cells in the tumor microenvironment is highlighted. The integrative concept of the hallmarks of cancer helps in understanding the mechanisms of cancer development and applying that knowledge to cancer medicine.

CANCER DISCOVERY (2022)

Add to Collection

Article Oncology

Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors

Xiaozhen Zhang et al.

Summary: Combination therapy with anti-TNFR2 and anti-PD-L1 can eradicate tumors, prolong overall survival, and activate robust antitumor immune response in advanced pancreatic ductal adenocarcinoma.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Review Oncology

Cancer-associated fibroblasts in the single-cell era

Dor Lavie et al.

Summary: Cancer-associated fibroblasts (CAFs) play a central role in the microenvironment of solid tumors, and recent advances in single-cell technologies have provided insights into their complexity and heterogeneity. Understanding the subsets and functions of CAFs can potentially lead to better therapeutic strategies for cancer.

NATURE CANCER (2022)

Add to Collection

Article Oncology

Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment

Chiara Falcomata et al.

Summary: In this study, a synergistic combination of nintedanib and trametinib is identified to sensitize mesenchymal PDAC to immune checkpoint blockade, providing a new strategy for treating this aggressive and therapy-refractory PDAC subtype.

NATURE CANCER (2022)

Add to Collection

Article Gastroenterology & Hepatology

CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer

Jin Huang et al.

Summary: Inhibition of CDK1/2/5 kinase activity can overcome IFNG-mediated immune evasion in pancreatic tumors, turning a 'cold' tumor microenvironment into a 'hot' one and significantly improving overall survival rates in mouse pancreatic tumor models. Abnormal expression of CDK1/2/5 and IDO1 is associated with poor patient survival in various cancer types, including PDAC.

GUT (2021)

Add to Collection

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice

Ivana Peran et al.

Summary: The study showed that CDH11, expressed by cancer-associated fibroblasts in the pancreatic tumor stroma, plays a critical role in promoting tumor growth and immunosuppression. Knockout or inhibition of CDH11 reduced pancreatic tumor growth, increased response to gemcitabine, and significantly extended survival of mice. Thus, CDH11 may be a potential therapeutic target for pancreatic cancer.

GASTROENTEROLOGY (2021)

Add to Collection

Article Oncology

EMT-Induced Gemcitabine Resistance in Pancreatic Cancer Involves the Functional Loss of Equilibrative Nucleoside Transporter 1

Brenna Weadick et al.

Summary: This study demonstrates that EMT in pancreatic cancer leads to decreased chemosensitivity to gemcitabine, with N-cadherin and EpCAM playing important roles in regulating ENT1 expression and membrane localization. Tumors expressing EpCAM had higher ENT1 levels and reduced metastasis, while tumors with N-cadherin expression were resistant to gemcitabine and formed extensive secondary metastatic nodules. Co-expression of EpCAM and ENT1 positively predicted survival in patients treated with adjuvant gemcitabine.

MOLECULAR CANCER THERAPEUTICS (2021)

Add to Collection

Article Oncology

Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer

Yang Chen et al.

Summary: The stromal desmoplastic reaction in pancreatic ductal adenocarcinoma involves significant accumulation of type I collagen (Col1). Deletion of Col1 specifically in myofibroblasts accelerates PDAC progression by increasing Cxcl5 expression in cancer cells and promoting recruitment of myeloid-derived suppressor cells. Targeting CXCR2 and CCR2 may help restrain accelerated PDAC progression in the absence of stromal Col1.

CANCER CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy

Kazuhiro Koikawa et al.

Summary: Upregulation of Pin1 in PDAC contributes to the desmoplastic and immunosuppressive TME, but targeting Pin1 with available drugs can synergize with immunotherapy and gemcitabine to induce complete elimination of PDAC.

CELL (2021)

Add to Collection

Article Health Care Sciences & Services

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

Andras Lanczky et al.

Summary: The web-based tool introduced in this study enables univariate and multivariate Cox proportional hazards survival analysis using data from various genomic studies, filling a significant gap in the field where no commonly used spreadsheet software or web server is available for this purpose.

JOURNAL OF MEDICAL INTERNET RESEARCH (2021)

Add to Collection

Article Multidisciplinary Sciences

NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1

Xiaozhen Zhang et al.

Summary: The study reveals that NEK2 phosphorylates PD-L1 to maintain stability, impacting the efficacy of immunotherapy in pancreatic cancer, while NEK2 deficiency enhances lymphocyte infiltration and sensitivity to immunotherapy. Inhibiting NEK2 can enhance PD-L1 blockade, potentially improving the effectiveness of pancreatic cancer treatment.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Biology

CXCL10/CXCR3 signaling contributes to an inflammatory microenvironment and its blockade enhances progression of murine pancreatic precancerous lesions

Veethika Pandey et al.

Summary: This study highlights the importance of CXCL10/CXCR3 signaling in the early phase of murine pancreatic cancer, demonstrating its role in mediating chemotaxis, proliferation, and maintenance of inflammatory identity in macrophages within the pancreas. Inhibition of CXCL10/CXCR3 signaling shifts macrophage populations to a tumor-promoting phenotype, increasing fibrosis and lesion progression.

ELIFE (2021)

Add to Collection

Article Oncology

CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways

Xiaona Chen et al.

Summary: Persistent HPV infection may induce cervical cancer cells to secrete CXCL10, which binds to CXCR3 in surrounding fibroblast cells, activating the JAK-STAT pathway and subsequently upregulating the expression of exosomal PD-L1.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Oncology

The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities

Won Jin Ho et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Add to Collection

Article Cell Biology

Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions

Min Tang et al.

CELL RESEARCH (2020)

Add to Collection

Article Oncology

A framework for advancing our understanding of cancer-associated fibroblasts

Erik Sahai et al.

NATURE REVIEWS CANCER (2020)

Add to Collection

Article Gastroenterology & Hepatology

Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets

Martin C. Whittle et al.

GASTROENTEROLOGY (2019)

Add to Collection

Article Oncology

Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival

Ludmila Danilova et al.

CANCER IMMUNOLOGY RESEARCH (2019)

Add to Collection

Article Oncology

Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer

Tsz-Lun Yeung et al.

CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Oncology

Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts

Ela Elyada et al.

CANCER DISCOVERY (2019)

Add to Collection

Article Multidisciplinary Sciences

ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer

Praneeth R. Kuninty et al.

SCIENCE ADVANCES (2019)

Add to Collection

Article Gastroenterology & Hepatology

Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer

E. Hessmann et al.

GUT (2018)

Add to Collection

Article Medicine, Research & Experimental

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance

Cecilia S. Leung et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Add to Collection

Article Oncology

CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer

Chenlu Zhang et al.

BMC CANCER (2018)

Add to Collection

Article Immunology

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Daniel Ohlund et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Add to Collection

Review Multidisciplinary Sciences

Elements of cancer immunity and the cancer-immune set point

Daniel S. Chen et al.

NATURE (2017)

Add to Collection

Article Biophysics

Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase

Christopher C. DuFort et al.

BIOPHYSICAL JOURNAL (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

Hong Jiang et al.

NATURE MEDICINE (2016)

Add to Collection

Review Cell Biology

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

Weiping Zou et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Add to Collection

Article Medicine, General & Internal

Pancreatic cancer

Jorg Kleeff et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Add to Collection

Article Gastroenterology & Hepatology

YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors

Patricia Marti et al.

HEPATOLOGY (2015)

Add to Collection

Letter Oncology

Compression of Pancreatic Tumor Blood Vessels by Hyaluronan Is Caused by Solid Stress and Not Interstitial Fluid Pressure

Vikash P. Chauhan et al.

CANCER CELL (2014)

Add to Collection

Article Oncology

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Berna C. Oezdemir et al.

CANCER CELL (2014)

Add to Collection

Article Oncology

Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma

Andrew D. Rhim et al.

CANCER CELL (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy

Mara H. Sherman et al.

CELL (2014)

Add to Collection

Article Multidisciplinary Sciences

Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential

Cecilia S. Leung et al.

NATURE COMMUNICATIONS (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Deletion of STK40 Protein in Mice Causes Respiratory Failure and Death at Birth

Hongyao Yu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Add to Collection

Article Oncology

Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma

Paolo P. Provenzano et al.

CANCER CELL (2012)

Add to Collection

Article Medicine, General & Internal

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Marco Gerlinger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Add to Collection

Article Medicine, General & Internal

Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Add to Collection

Article Oncology

A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2

Samuel C. Mok et al.

CANCER CELL (2009)

Add to Collection

Article Multidisciplinary Sciences

Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations

Nikola Wenta et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Add to Collection

Article Hematology

Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-γ and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway

Jizhong Liu et al.

BLOOD (2007)

Add to Collection

Article Cardiac & Cardiovascular Systems

IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain

RJ Bodnar et al.

CIRCULATION RESEARCH (2006)

Add to Collection

Article Gastroenterology & Hepatology

Desmoplastic reaction in pancreatic cancer - Role of pancreatic stellate cells

MV Apte et al.

PANCREAS (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.